Please try another search
BAGSVÆRD, Denmark - Novo Nordisk (NYSE:NVO), a global healthcare company, has announced its agreement to purchase Cardior Pharmaceuticals for up to €1.025 billion, which includes both an...
COPENHAGEN (Reuters) - The Danish central bank on Wednesday almost doubled its forecast for economic growth this year due to strong production by drug maker Novo Nordisk (CSE:NOVOb) and the restart...
By Bansari Mayur Kamdar and Amruta Khandekar (Reuters) -Wall Street was set to open higher on Thursday ahead of more economic data and commentary from Jerome Powell after the Federal Reserve chair...
Danish biotechnology research company Zealand Pharma (ZLDPF) saw its shares soar more than 35% in Copenhagen on Monday after following positive results from a trial of its liver disease treatment,...
Pharmaceutical companies Novo Nordisk (NYSE:NVO) A/S, GSK Plc, Haleon Plc, and BASF SE (OTC:BASFY) are scheduled to announce their financial results next week amidst a range of market conditions. Novo...
Novo Nordisk (NYSE:NVO), currently the most valuable European company, has revised its full-year guidance upwards, primarily due to a surge in U.S. sales of its semaglutide-based drugs, Wegovy and...
By Maggie Fick COPENHAGEN (Reuters) - The whirlwind success of weight-loss treatment Wegovy is providing a bonanza not just for its developer, Novo Nordisk (CSE:NOVOb), but also for its home...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review